NICOLE BAKER, CEO, Biologit

•   CEO at biologit, a Technology Company focused on Artificial Intelligence for Active Safety Surveillance.

•   Immunologist and Pharmacovigilance Professional with strong focus on innovation and extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams.

•   Extensive experience in providing strategic, operational and scientific leadership throughout the product life-cycle, from pre-clinical to post-marketing.

•   Experience gained supporting or fulfilling the role of EEA QPPV and RPPV in Clinical Trials over the past 10 years.

•   Over 20 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority, Clinical Research Organisation, and more recently Start-up.